About Yvonne Yamanaka
Form D filings for ImmPACT Bio USA from 2022 to 2024 list Yvonne Yamanaka as director.
Yvonne Yamanaka first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Yvonne Yamanaka in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Yvonne Yamanaka works with at each company, as listed on that company's latest Form D.
ImmPACT Bio USA Inc. · Form D/A, Apr 2, 2024
YC
Yvonne Chen
Director
Erez Chimovits
Director
HL
Han Lee
Executive officer
MS
Michal Silverberg
Director
XC
Xiangmin Cui
Director
SG
Sheila Guirathi
Director
SR
Sumant Ramachandra
President and Chief Executive Officer, director
CX
Cindy Xiong
Director